Literature DB >> 23929321

Myriad decision aftershocks ripple through biotech.

Mark Ratner.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23929321     DOI： 10.1038/nbt0813-663

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Industry reels as Prometheus falls and Myriad faces further reviews.

Authors:  Jeffrey L Fox
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

Review 2.  Patenting pluripotence: the next battle for stem cell intellectual property.

Authors:  Katja Triller Vrtovec; Christopher Thomas Scott
Journal:  Nat Biotechnol       Date:  2008-04       Impact factor: 54.908

3.  Not quite a myriad of gene patents.

Authors:  Gregory D Graff; Devon Phillips; Zhen Lei; Sooyoung Oh; Carol Nottenburg; Philip G Pardey
Journal:  Nat Biotechnol       Date:  2013-05       Impact factor: 54.908
  3 in total
  6 in total

1.  The impact of patent eligibility on biotech patents: A flow chart for determining patent eligibility and an immune therapy case study.

Authors:  Bao-Chi Chang; Shyh-Jen Wang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Patenting natural products just got harder.

Authors:  Charlotte Harrison
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

3.  Myriad diversifies, fights rearguard action on patents.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2014-03       Impact factor: 54.908

4.  Myriad's impact on gene patents.

Authors:  Mateo Aboy; Kathleen Liddell; Johnathon Liddicoat; Cristina Crespo
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

5.  Cancer biomarker discovery and validation.

Authors:  Nicolas Goossens; Shigeki Nakagawa; Xiaochen Sun; Yujin Hoshida
Journal:  Transl Cancer Res       Date:  2015-06       Impact factor: 1.241

6.  Availability and payer coverage of BRCA1/2 tests and gene panels.

Authors:  Elizabeth Clain; Julia R Trosman; Michael P Douglas; Christine B Weldon; Kathryn A Phillips
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.